Pro-inflammatory cytokines, such as IL-6 and TNF-α, are significantly elevated in lung cancer patients and contribute to endothelial dysfunction, plaque instability, and increased coagulation, all of which heighten cardiovascular risk (27, 28). Here, IL6 is linked to lung cancer.